US2023374529A1PendingUtilityA1
Reconstruction of site specific nuclease binding sites
Est. expiryDec 14, 2036(~10.4 yrs left)· nominal 20-yr term from priority
Inventors:David R. CorbinWei ChenStephen NovakRyan M. LeeSandeep KumarAndrew AsberryAndrew F. Worden
C12N 9/222C12N 15/8213C12N 9/22C12Y 301/21004C12N 15/8261C12N 15/8209C12N 15/8286C12N 15/8274C12N 15/90Y02A40/146
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are methods and compositions for the repair of site specific nuclease binding sites by targeted integration and/or targeted excision of one or more sequences into a cell.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 .- 20 . (canceled)
21 . A method for targeted excision of a donor polynucleotide from a plant genome, the method comprising the following steps:
a. Stably inserting the donor polynucleotide sequence within the plant genome; b. Introducing a site specific nuclease to bind a site specific nuclease binding site, wherein the site specific nuclease binding site flanks the donor polynucleotide; c. Cleaving at least one site specific nuclease binding site; d. Removing the donor polynucleotide sequence from the plant genome; e. Recombining the site specific nuclease binding sites that flank the donor polynucleotide, wherein the recombined site specific nuclease binding site is identical to the site specific nuclease binding site.
22 . The method of claim 21 , wherein the site specific nuclease is selected from the group consisting of a Zinc Finger nuclease, a CRISPR nuclease, a TALEN nuclease, or any combination thereof.
23 . The method of claim 21 , wherein the donor polynucleotide sequence is completely removed from the genome.
24 . The method of claim 23 , wherein the donor polynucleotide sequence comprises a transgene.
25 . The method of claim 24 , wherein the transgene encodes a selectable marker.
26 . The method of claim 21 , wherein the repaired site specific nuclease binding site is repaired via a NHEJ-mediated cellular process.
27 . The method of claim 21 , wherein the repaired site specific nuclease binding site is greater than 6 bp in length.
28 . The method of claim 21 , wherein the site specific nuclease binding sites are within 3,000 bp to 4,000 bp of one another.
29 . The method of claim 21 , wherein the recombined site specific nuclease does not comprise an INDEL.
30 . The method of claim 21 , wherein the donor polynucleotide that is flanked by the site specific nuclease binding sites comprise either a native genomic sequence or a transgenic sequence within a genome of a eukaryotic organism.
31 . The method of claim 21 , the method further comprising the steps of:
a. Targeting the recombined site specific nuclease binding site with the site specific nuclease; b. Cleaving the recombined site specific nuclease binding site with the site specific nuclease; c. Introducing a second donor polynucleotide sequence; d. Integrating the second donor polynucleotide sequence within the cleaved site specific nuclease binding site; and e. Producing a genome comprising the second donor polynucleotide sequence stably integrated within the plant genome.
32 . The method of claim 21 , wherein the donor polynucleotide sequence comprises a polynucleotide encoding a transgene or a gene expression cassette.
33 . The method of claim 21 , wherein the site specific nuclease binding site is palindromic.
34 . The method of claim 21 , wherein the site specific nuclease binding site is non-palindromic.
35 . The method of claim 21 , wherein the recombined site specific nuclease binding site is inherited in a progeny.Join the waitlist — get patent alerts
Track US2023374529A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.